A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Condition: Cholestasis, IntrahepaticInterventions: Drug: GSK2330672; Drug: Placebo; Drug: Ursodeoxycholic acidSponsors: GlaxoSmithKline; GlaxoSmithKlineNot yet recruiting - verified October 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials